| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |